Sangamo Therapeutics
SGMO
#10549
Rank
โ‚ฌ27.94 M
Marketcap
0,06746ย โ‚ฌ
Share price
0.00%
Change (1 day)
-80.05%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -โ‚ฌ94.3 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ34.55 Million. In 2025 the company made an earning of -โ‚ฌ98.46 Million a decrease over its 2024 earnings that were of -โ‚ฌ89.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ94.3 Million-4.22%
2025 -โ‚ฌ98.46 Million9.71%
2024 -โ‚ฌ89.75 Million-17.27%
2023 -โ‚ฌ0.11 Billion-40.88%
2022 -โ‚ฌ0.19 Billion9.79%
2021 -โ‚ฌ0.17 Billion41.52%
2020 -โ‚ฌ0.12 Billion23.17%
2019 -โ‚ฌ95.89 Million36.33%
2018 -โ‚ฌ70.33 Million36.89%
2017 -โ‚ฌ51.38 Million-22.32%
2016 -โ‚ฌ66.15 Million54.86%
2015 -โ‚ฌ42.72 Million75.62%
2014 -โ‚ฌ24.33 Million0.13%
2013 -โ‚ฌ24.3 Million
2011 -โ‚ฌ32.66 Million43.66%
2010 -โ‚ฌ22.74 Million28.52%
2009 -โ‚ฌ17.69 Million-23.55%
2008 -โ‚ฌ23.14 Million2.45%
2007 -โ‚ฌ22.59 Million19.5%
2006 -โ‚ฌ18.9 Million50.78%
2005 -โ‚ฌ12.54 Million75%
2004 -โ‚ฌ7.17 Million-33.25%
2003 -โ‚ฌ10.73 Million-62.27%
2002 -โ‚ฌ28.44 Million102.82%
2001 -โ‚ฌ14.03 Million23.21%
2000 -โ‚ฌ11.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.06 B-17,069.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ10.07 B-10,117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ0.40 B-503.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚ฌ0.39 Billion 285.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚ฌ2.31 Billion 2,196.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.12 B-6,193.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ1.11 B-1,207.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ39.8 M-139.58%๐Ÿ‡บ๐Ÿ‡ธ USA